Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer.

Takamoto, Atsushi; Tanimoto, Ryuta; Bekku, Kensuke; Araki, Motoo; Sadahira, Takuya; Wada, Koichiro; Ebara, Shin; Katayama, Norihisa; Yanai, Hiroyuki; Nasu, Yasutomo

Takamoto, Atsushi; Tanimoto, Ryuta; Bekku, Kensuke; Araki, Motoo; Sadahira, Takuya; Wada, Koichiro; Ebara, Shin; Katayama, Norihisa; Yanai, Hiroyuki; Nasu, Yasutomo.

Afiliación

Takamoto A; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Tanimoto R; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Bekku K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Sadahira T; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Wada K; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ebara S; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Katayama N; Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yanai H; Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Nasu Y; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Int J Urol ; 25(5): 507-512, 2018 05.

Article en En | MEDLINE | ID: mdl-29651796

Asunto(s)

Braquiterapia/métodos; Hormonas/uso terapéutico; Radioisótopos de Yodo/uso terapéutico; Terapia Neoadyuvante; Neoplasias de la Próstata/mortalidad; Neoplasias de la Próstata/terapia; Anciano; Terapia Combinada; Humanos; Japón/epidemiología; Masculino; Persona de Mediana Edad; Análisis Multivariante; Estadificación de Neoplasias; Antígeno Prostático Específico/sangre; Neoplasias de la Próstata/radioterapia; Dosificación Radioterapéutica; Estudios Retrospectivos; Medición de Riesgo; Índice de Severidad de la Enfermedad; Análisis de Supervivencia; Factores de Tiempo; Resultado del Tratamiento

Palabras clave

brachytherapy; iodine-125; neoadjuvant hormonal therapy; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia / Terapia Neoadyuvante / Hormonas / Radioisótopos de Yodo Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google